Catheter-free, electrophysiology (EP)-guided, noninvasive cardiac radioablation has been used on small numbers of patients to treat ventricular tachycardia (VT), but long-term follow-up for safety, efficacy and survival has been lacking. A late-breaking study presented at Heart Rhythm 2023 in May showed positive outcomes for this new ablation method.